Reumatologia Clinica最新文献

{"title":"Elaboración de un protocolo asistencial en el embarazo y las artritis inflamatorias crónicas, en un grupo de trabajo multidisciplinar","authors":"Andrea Pluma ,&nbsp;Laia Alsina ,&nbsp;Estefanía Moreno ,&nbsp;Rafael Touriño ,&nbsp;Manel Casellas ,&nbsp;Dolors Grados ,&nbsp;Grup de Treball de Societat Catalana de Reumatologia FEMCAT","doi":"10.1016/j.reuma.2024.03.003","DOIUrl":"https://doi.org/10.1016/j.reuma.2024.03.003","url":null,"abstract":"<div><h3>Objective</h3><p>To design a care protocol in chronic inflammatory arthritis during the pre-conceptional period, pregnancy, postpartum and lactation. This protocol aims to be practical and applicable in consultations where patients with chronic inflammatory rheumatological diseases are treated, thus helping to better control these patients. Likewise, recommendations are offered on when patients could be consulted/referred to a specialized center by the physician.</p></div><div><h3>Methods</h3><p>A multidisciplinary panel of expert physicians from different specialties identified the key points, analyzed the scientific evidence, and met to develop the care protocol.</p></div><div><h3>Results</h3><p>The recommendations prepared have been divided into three blocks: rheumatology, gynecology and pediatrics. The first block has been divided into pre-pregnancy, pregnancy and postpartum visits.</p></div><div><h3>Conclusions</h3><p>This protocol tries to homogenize the follow-up of the patients from the moment of the gestational desire until the year of life of the infants. It is important to perform tests in patients of childbearing age and use drugs compatible with pregnancy. If appropriate, the patient should be referred to specialized units. Multidisciplinarity (rheumatology, gynecology and pediatrics) is essential to improve the control and monitoring of these patients and their offspring.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 6","pages":"Pages 320-325"},"PeriodicalIF":1.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141435176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Síndrome de VEXAS: a propósito de una serie de 2 casos","authors":"Adrián Mayo-Juanatey ,&nbsp;María José Fernández-Llavador ,&nbsp;María del Mar Fernández-Garcés ,&nbsp;Elia Valls-Pascual ,&nbsp;Juan José Alegre-Sancho","doi":"10.1016/j.reuma.2024.05.003","DOIUrl":"https://doi.org/10.1016/j.reuma.2024.05.003","url":null,"abstract":"<div><p>VEXAS syndrome is a rare entity secondary to UBA1 gene mutations, located on the X chromosome. This mutation generates, as a consequence, a characteristic vacuolation on haematopoietic stem-cells. It is characterized by multiple autoinflammatory and haematologic manifestations, which respond and end up being dependent on corticosteroid treatment. In this publication we present a 2-case series diagnosed at our hospital and make a brief literature review of the published evidence so far.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 6","pages":"Pages 341-344"},"PeriodicalIF":1.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141435182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Índice de autores","authors":"","doi":"10.1016/S1699-258X(24)00066-4","DOIUrl":"https://doi.org/10.1016/S1699-258X(24)00066-4","url":null,"abstract":"","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 ","pages":"Pages S552-S571"},"PeriodicalIF":1.5,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1699258X24000664/pdfft?md5=f27118a83a10f6a5cd402cc6e47769b8&pid=1-s2.0-S1699258X24000664-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141095361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Actualización de las Guías para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología 2023","authors":"Carlos Abud-Mendoza ,&nbsp;Francisco Javier Aceves-Ávila ,&nbsp;César Alejandro Arce-Salinas ,&nbsp;José Álvarez Nemegyei ,&nbsp;Leonor Barile-Fabris ,&nbsp;Sergio Durán-Barragán ,&nbsp;Diana Elsa Flores-Alvarado ,&nbsp;Eufrates Hernández-Núñez ,&nbsp;Fedra Irazoque-Palazuelos ,&nbsp;José Francisco Moctezuma-Ríos ,&nbsp;Virginia Pascual-Ramos ,&nbsp;Margarita Portela-Hernández ,&nbsp;Luis Humberto Silveira ,&nbsp;Lilia Andrade-Ortega ,&nbsp;Ana Barrera-Vargas ,&nbsp;Sandra Carrillo-Vázquez ,&nbsp;Zully Castro-Colin ,&nbsp;Enrique Cuevas-Orta ,&nbsp;Luis Felipe Flores-Suárez ,&nbsp;Guillermo Arturo Guaracha-Basáñez ,&nbsp;César Pacheco-Tena","doi":"10.1016/j.reuma.2024.02.002","DOIUrl":"10.1016/j.reuma.2024.02.002","url":null,"abstract":"<div><h3>Objective</h3><p>To develop updated guidelines for the pharmacological management of rheumatoid arthritis (RA).</p></div><div><h3>Methods</h3><p>A group of experts representative of different geographical regions and various medical services catering to the Mexican population with RA was formed. Questions based on Population, Intervention, Comparison, and Outcome (PICO) were developed, deemed clinically relevant. These questions were answered based on the results of a recent systematic literature review (SLR), and the evidence's validity was assessed using the GRADE system, considered a standard for these purposes. Subsequently, the expert group reached consensus on the direction and strength of recommendations through a multi-stage voting process.</p></div><div><h3>Results</h3><p>The updated guidelines for RA treatment stratify various therapeutic options, including different classes of DMARDs (conventional, biologicals, and JAK inhibitors), as well as NSAIDs, glucocorticoids, and analgesics. By consensus, it establishes the use of these in different subpopulations of interest among RA patients and addresses aspects related to vaccination, COVID-19, surgery, pregnancy and lactation, and others.</p></div><div><h3>Conclusions</h3><p>This update of the Mexican guidelines for the pharmacological treatment of RA provides reference points for evidence-based decision-making, recommending patient participation in joint decision-making to achieve the greatest benefit for our patients. It also establishes recommendations for managing a variety of relevant conditions affecting our patients.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 5","pages":"Pages 263-280"},"PeriodicalIF":1.5,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140764337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pósteres: P200-P299","authors":"","doi":"10.1016/S1699-258X(24)00063-9","DOIUrl":"https://doi.org/10.1016/S1699-258X(24)00063-9","url":null,"abstract":"","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 ","pages":"Pages S312-S397"},"PeriodicalIF":1.5,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141094895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Junta Directiva de la SER, Comité de Organización de Congresos, Comité Científico del Congreso y Comité Organizador Local del Congreso","authors":"","doi":"10.1016/S1699-258X(24)00058-5","DOIUrl":"https://doi.org/10.1016/S1699-258X(24)00058-5","url":null,"abstract":"","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 ","pages":"Page i"},"PeriodicalIF":1.5,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1699258X24000585/pdfft?md5=b7d147f2f3cb7a2fca4d8730541b13f1&pid=1-s2.0-S1699258X24000585-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141095518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Escorbuto. Una pseudovasculitis olvidada","authors":"Noelia Cabaleiro-Raña ,&nbsp;Diego Santos-Álvarez ,&nbsp;Lucía Romar de las Heras ,&nbsp;Carmen Álvarez-Reguera ,&nbsp;Evelin Cecilia Cervantes Pérez ,&nbsp;Rosa María Hernández Cancela ,&nbsp;Susana Romero-Yuste","doi":"10.1016/j.reuma.2024.01.001","DOIUrl":"10.1016/j.reuma.2024.01.001","url":null,"abstract":"<div><p>Scurvy is a nutritional disease caused by ascorbic acid (vitamin C) deficiency. Althought currently it is a rare disease, we should considerer it in the differential diagnosis of purpura and arthritis in patients with restrictive diets.</p><p>We present the case of a 49-year-old man with a history of a nutritional disorder presented to our hospital with generalized purpura and hemarthros. Following the anamnesis and laboratory findings, rheumatological, infectious and hematological etiologies were excluded. Finally, the diagnosis of scurvy was made upon demostration poor levels of vitamin C and a spectacular response to nutritional supplements. We compare this case with 19 similar cases reported in the medical literature.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 5","pages":"Pages 281-285"},"PeriodicalIF":1.5,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140466168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pósteres: P300-P399","authors":"","doi":"10.1016/S1699-258X(24)00064-0","DOIUrl":"https://doi.org/10.1016/S1699-258X(24)00064-0","url":null,"abstract":"","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 ","pages":"Pages S397-S489"},"PeriodicalIF":1.5,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141094896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Trabajos aceptados solo para publicación","authors":"","doi":"10.1016/S1699-258X(24)00060-3","DOIUrl":"https://doi.org/10.1016/S1699-258X(24)00060-3","url":null,"abstract":"","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 ","pages":"Pages S55-S130"},"PeriodicalIF":1.5,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141094892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cardiopulmonary phenotype in systemic sclerosis associated pulmonary hypertension","authors":"Luis Javier Cajas Santana ,&nbsp;Alejandro Correa Giraldo ,&nbsp;Maria Carolina Torres","doi":"10.1016/j.reuma.2024.01.004","DOIUrl":"10.1016/j.reuma.2024.01.004","url":null,"abstract":"<div><h3>Introduction</h3><p>Pulmonary hypertension (PH) associated with systemic sclerosis (SSc) increases morbidity and mortality. Cardiopulmonary comorbidities, as per the 2021 PH consensus, play a role in the choice of therapy between monotherapy and combination therapy.</p></div><div><h3>Methods</h3><p>A cross-sectional study was conducted in patients with SSc based on the 2013 ACR/EULAR criteria or very early disease (VEDOSS 2011). PH was considered if they met the following criteria: pulmonary artery systolic pressure (PASP)<!--> <!-->&gt;<!--> <!-->39<!--> <!-->mmHg or peak tricuspid regurgitation velocity (PTRV)<!--> <!-->&gt;<!--> <!-->3.4<!--> <!-->m/s, PASP between 33 and 39<!--> <!-->mmHg or PTRV between 2.9 and 3.4<!--> <!-->m/s plus two additional findings suggestive of PH. PH was classified as type 2 if LVEF<!--> <!-->&lt;<!--> <!-->50% or moderate to severe diastolic dysfunction was present; type 3 if extensive interstitial disease on tomography<!--> <!-->&gt;<!--> <!-->20% or forced vital capacity (FVC)<!--> <!-->&lt;<!--> <!-->75%; type 4 if abnormalities related to embolism were detected on scintigraphy or tomography. If patients did not meet these criteria, they were classified as type 1 PH. Complete data on cardiopulmonary risk factors and other factors were required. The frequency of these factors in the population and differences between groups based on risk factors were estimated.</p></div><div><h3>Results</h3><p>A total of 228 patients were selected. Three had type 2 PH, 24 had type 3, and 40 had type 1 PH, with the majority (75%) having at least one cardiopulmonary risk factor, and 47.5% having more than one. Mild diastolic dysfunction (25%) and hypertension (35%) were the most prevalent. In the type 1 PH group, those with risk factors experienced an increase in the number of years with Raynaud's phenomenon, anticentromere antibodies, and gastrointestinal symptoms (<em>p</em> <!-->&lt;<!--> <!-->0.05).</p></div><div><h3>Conclusion</h3><p>In patients with PH, 75% have one, and 45% have two or more risk factors.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 5","pages":"Pages 243-248"},"PeriodicalIF":1.5,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140089151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}